These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25838919)

  • 1. Pharmaceutical supply chain risk assessment in Iran using analytic hierarchy process (AHP) and simple additive weighting (SAW) methods.
    Jaberidoost M; Olfat L; Hosseini A; Kebriaeezadeh A; Abdollahi M; Alaeddini M; Dinarvand R
    J Pharm Policy Pract; 2015; 8(1):9. PubMed ID: 25838919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical supply chain risks: a systematic review.
    Jaberidoost M; Nikfar S; Abdollahiasl A; Dinarvand R
    Daru; 2013 Dec; 21(1):69. PubMed ID: 24355166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An application of multi-criteria decision-making approach to sustainable drug shortages management: evidence from a developing country.
    Moosivand A; Rangchian M; Zarei L; Peiravian F; Mehralian G; Sharifnia H
    J Pharm Health Care Sci; 2021 Apr; 7(1):14. PubMed ID: 33795021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing a suitable model for supplier selection based on supply chain risks: an empirical study from Iranian pharmaceutical companies.
    Mehralian G; Rajabzadeh Gatari A; Morakabati M; Vatanpour H
    Iran J Pharm Res; 2012; 11(1):209-19. PubMed ID: 24250442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk assessment of supply chain for pharmaceutical excipients with AHP-fuzzy comprehensive evaluation.
    Li M; Du Y; Wang Q; Sun C; Ling X; Yu B; Tu J; Xiong Y
    Drug Dev Ind Pharm; 2016; 42(4):676-84. PubMed ID: 26288999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk assessment of supply chain for pharmaceutical excipients with AHP-fuzzy comprehensive evaluation.
    Li M; Du Y; Wang Q; Sun C; Ling X; Yu B; Tu J; Xiong Y
    Drug Dev Ind Pharm; 2016 Apr; 42(4):676-684. PubMed ID: 26266963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical Success Factors of a Drug Traceability System for Creating Value in a Pharmaceutical Supply Chain (PSC).
    Silva RBD; Mattos CA
    Int J Environ Res Public Health; 2019 Jun; 16(11):. PubMed ID: 31167350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of regulatory requirements on medicine registration in African countries - perceptions and experiences of pharmaceutical companies in South Africa.
    Narsai K; Williams A; Mantel-Teeuwisse AK
    South Med Rev; 2012 Jul; 5(1):31-7. PubMed ID: 23093897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies to improve pharmaceutical supply chain resilience under politico-economic sanctions: the case of Iran.
    Bastani P; Dehghan Z; Kashfi SM; Dorosti H; Mohammadpour M; Mehralian G; Ravangard R
    J Pharm Policy Pract; 2021 Jul; 14(1):56. PubMed ID: 34225794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing a Risk Reduction Support System for Health System in Iran: A Case Study in Blood Supply Chain Management.
    Sibevei A; Azar A; Zandieh M; Khalili SM; Yazdani M
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local causes of essential medicines shortages from the perspective of supply chain professionals in Saudi Arabia.
    AlRuthia Y; Mohammed Almutiri N; Musa Almutairi R; Almohammed O; Alhamdan H; Ali El-Haddad S; Abdu Asiri Y
    Saudi Pharm J; 2023 Jun; 31(6):948-954. PubMed ID: 37234344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Product Development in the Pharmaceutical Industry: Evidence from a generic market.
    Yousefi N; Mehralian G; Rasekh HR; Yousefi M
    Iran J Pharm Res; 2017; 16(2):834-846. PubMed ID: 28979339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated Multicriteria Decision-Making Methods to Solve Supplier Selection Problem: A Case Study in a Hospital.
    Akcan S; Güldeş M
    J Healthc Eng; 2019; 2019():5614892. PubMed ID: 31687120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interval valued intuitionistic fuzzy analytic hierarchy process-based green supply chain resilience evaluation methodology in post COVID-19 era.
    Ayyildiz E
    Environ Sci Pollut Res Int; 2023 Mar; 30(15):42476-42494. PubMed ID: 34669128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicriteria Decision Making in Supply Chain Management Using FMEA and Hybrid AHP-PROMETHEE Algorithms.
    Altubaishe B; Desai S
    Sensors (Basel); 2023 Apr; 23(8):. PubMed ID: 37112382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating risks and strategies in adopting green tourism practices in developing economy.
    Luo Z; Yun L
    Environ Sci Pollut Res Int; 2023 Dec; 30(59):123710-123728. PubMed ID: 37989948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Information flow in the pharmaceutical supply chain.
    Yousefi N; Alibabaei A
    Iran J Pharm Res; 2015; 14(4):1299-303. PubMed ID: 26664401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The solutions to increase the participation of men in sexual and reproductive health of women in Iran: an analytic hierarchy process (AHP) analysis.
    Sarafraz N; Taghizadeh Z; Jafari N; Ghiasi A
    J Obstet Gynaecol; 2022 Jul; 42(5):1410-1414. PubMed ID: 34913806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing internal control in public hospital supply chain: a game theory-based approach.
    Yu Z
    Front Public Health; 2023; 11():1240757. PubMed ID: 37920582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impacts of international sanctions on Iranian pharmaceutical market.
    Cheraghali AM
    Daru; 2013 Jul; 21(1):64. PubMed ID: 23902642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.